Immunogenicity and safety of one-dose human papillomavirus vaccine compared with two or three doses in Tanzanian girls (DoRIS): an open-label, randomised, non-inferiority trial oleh Deborah Watson-Jones, ProfPhD, John Changalucha, MSc, Hilary Whitworth, PhD, Ligia Pinto, PhD, Paul Mutani, MD, Jackton Indangasi, MSc, Troy Kemp, PhD, Ramadhan Hashim, BSc, Beatrice Kamala, Dip, Rebecca Wiggins, PhD, Twaib Songoro, BA, Nicholas Connor, MSc, Gladys Mbwanji, MSc, Miquel A Pavon, PhD, Brett Lowe, MSc, Devis Mmbando, BSc, Saidi Kapiga, ProfPhD, Philippe Mayaud, ProfMD, Silvia de SanJosé, MD, Joakim Dillner, ProfPhD, Richard J Hayes, ProfDSc, Charles J Lacey, ProfMD, Kathy Baisley, MSc